Pharmacodynamics of Cholinesterase Inhibitors Suggests Add-on Therapy with a Low-Dose Carbamylating Inhibitor in Patients on Long-Term Treatment with Rapidly Reversible Inhibitors-Reference-Cited by-同舟云学术

Pharmacodynamics of Cholinesterase Inhibitors Suggests Add-on Therapy with a Low-Dose Carbamylating Inhibitor in Patients on Long-Term Treatment with Rapidly Reversible Inhibitors

Published:2014-01-24 Issue:2 Volume:39 Page:423-440
ISSN:1875-8908
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Darreh-Shori Taher¹,Hosseini Sharokh Makvand¹²,Nordberg Agneta¹³

Affiliation:

1. Department of Neurobiology, Care Sciences and Society, Division of Alzheimer Neurobiology, Karolinska Institute, Stockholm, Sweden

2. Faculty of Psychology and Educational Sciences, Semnan University, Semnan, Iran

3. Department of Geriatric Medicine, Karolinska University Hospital Huddinge, Stockholm, Sweden

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repurposing Duloxetine as a Potent Butyrylcholinesterase Inhibitor: Potential Cholinergic Enhancing Benefits for Elderly Individuals with Depression and Cognitive Impairment;ACS Omega;2024-08-21

2. Acetylcholinesterase Inhibitors in the Treatment of Neurodegenerative Diseases and the Role of Acetylcholinesterase in their Pathogenesis;International Journal of Molecular Sciences;2021-08-27

3. CSF and Plasma Cholinergic Markers in Patients With Cognitive Impairment;Frontiers in Aging Neuroscience;2021-08-26

4. Serum Concentrations of Cholinesterase Inhibitors in Patients With Alzheimer’s Dementia Are Frequently Below the Recommended Levels;Frontiers in Pharmacology;2020-05-21

5. CSF Cholinergic Index, a New Biomeasure of Treatment Effect in Patients With Alzheimer’s Disease;Frontiers in Molecular Neuroscience;2019-10-11